The General Meeting is the corporate body that has the highest authority in Biotage. All shareholders may participate at the General Meetings.
The Annual General Meeting (the “AGM”) attends to such matters as the development of the Company’s business during the preceding fiscal year and resolutions are passed in a number of important items such as approving the Annual Report, disposition of the result of the year, dividends, discharge of the Board of Directors and the CEO, election of members of the Board of Directors and the auditors, fees and allocation of fees to the Board of Directors and the auditors, and guidelines for compensation of the executive management.
The notice for the AGM is published at the earliest six weeks prior to and no later than four weeks before the AGM.
A shareholder has the right to request that a certain item is made subject to the AGM. To ensure that the Company is able to amend such an item to the notice for the AGM, such request shall be with the Company no later than seven weeks prior to the AGM. The request to have an item addressed at the AGM shall be made to the Company’s Board of Directors at the address set out below:
Biotage AB
Attn. CFO
P.O. Box 8
SE-751 03 Uppsala
Sweden
The General Meeting does also resolve in such important matters as changes and amendments to the Articles of Association, share based incentive programs, issue of shares and derivatives of shares, authorization of the Board of Directors to resolve on the issue of shares and derivatives of shares, approval of issues of shares and derivatives shares that are resolved by the Board of Directors but conditioned to the approval of the General Meeting.
The Company may hold other General Meetings than the AGM. The notice for an extra ordinary General Meeting, were the subject is not the change of the Company’s Articles of Association, shall be published at the earliest six weeks prior to and not no later than two weeks before the General Meeting. If the subject of the General Meeting concerns a change of the Company’s Articles of Association, then the notice period for the AGM applies.
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage
Biotage är ett Globalt Go-To Separations-företag, som stödjer kunder inom forskning och tillverkning av läkemedel, diagnostik och analytiska tester, med intelligenta och hållbara arbetsflödeslösningar. Vår expertis och våra högkvalitativa separationslösningar spelar en nyckelroll för att effektivisera kunders arbetsflöden och förbättra deras resultat. Biotage har sitt huvudkontor i Sverige, 700 medarbetare globalt, och levererar lösningar till över 80 länder. Vårt företag är noterat på NASDAQ Stockholm (BIOT).
Copyright © 2020 Biotage
SEL-2EV
Two Channel, Extended Collection Bed, UV Detector